L Catterton Announces Sale of Thorne to The Procter & Gamble Company for $3.8 Billion

L Catterton has entered into a definitive agreement to sell Thorne, a prominent player in the science-backed health and wellness sector, to The Procter & Gamble Company for $3.8 billion in cash. This transaction, announced on August 4, 2026, follows a successful partnership between L Catterton and Thorne that has significantly accelerated the latter's growth in the wellness category. The deal is anticipated to close in the fourth quarter of 2026.

Thorne has established itself as a leader in the Vitamins, Minerals, and Supplements (VMS) category, capitalizing on a consumer trend toward proactive health management and clinically supported wellness solutions. L Catterton's investment in Thorne began in October 2023, driven by extensive research into evolving consumer behaviors that favor trusted, science-based products. The firm has played a crucial role in enhancing Thorne's market position by investing in leadership, marketing, research and development, and technology, thereby fortifying the brand's reputation for quality and scientific integrity.

Under L Catterton's stewardship, Thorne has made significant strides in expanding its reach and capabilities. The introduction of a proprietary AI wellness advisor exemplifies the company's commitment to enhancing consumer engagement and education. This technological advancement, alongside strengthened manufacturing processes and quality systems, has positioned Thorne to better serve both healthcare practitioners and consumers. The partnership has not only preserved the brand's foundational principles but has also propelled it into a new growth phase, aligning with the increasing consumer demand for reliable wellness solutions.

The acquisition by Procter & Gamble represents a strategic move to further integrate Thorne's innovative health solutions into a broader consumer health portfolio. Procter & Gamble, known for its extensive reach and marketing prowess, is well-positioned to leverage Thorne's scientific expertise and established brand trust. This transaction underscores the growing importance of wellness in consumer spending and reflects a broader trend within the consumer goods sector toward health-focused products.

As the market for health and wellness solutions continues to expand, this acquisition signals a significant shift in how major consumer brands are approaching the VMS category. The integration of Thorne into Procter & Gamble's operations may catalyze further innovation and investment in health-related products, ultimately benefiting consumers seeking reliable and scientifically-backed wellness solutions. The transaction highlights the ongoing transformation within the consumer goods landscape, as companies increasingly prioritize health and wellness in their strategic initiatives.